| 摘要 |
Disclosed is a topical pharmaceutical composition comprising (a) a cromolyn component selected from cromolyn, pharmaceutically acceptable salts thereof, analogs thereof, and any combination of the foregoing, and (b) a delivery agent of the formula (B) or a salt thereof, wherein the variables are as defined in the specification. Said topical pharmaceutical composition may further comprise (a) an excipient, (b) a cream, (c) an ointment base, (d) a viscosity building agent, (e) a moisturizer, (f) a preservative, (g) a dosing vehicle, or (h) any combination thereof; and it can be used for treating a skin condition selected from the group comprising atopic dermatitis and other eczematous disorders, mastocytosis, vernal deratoconjunctivitis, vernal conjunctivitis, vernal keratitis, skin wounds, skin infections, herpes simplex, herpes zoster, vaccinia virus or coxsackievirus, skin burns, decubitus ulcers, open sores, incisions, traumatic damage caused by irradiation of the skin, prevention of keloid scars and other scar tissue, vulvar vestibulitis, interstitial cystitis, vulvar vaginitis or vaginitis dynea, psoriasis, uremic pruritus, hemangioma, allergic rhinitis (hay fever), and "sinus" headaches. |
